Two key factors set us apart from other actors in global health:

  • The partnership model: as a public-private partnership, we capitalise on the sum of our partners’ comparative advantages;
  • The business model: by pooling demand for vaccines from the world’s poorest countries, securing long-term funding and shaping vaccine markets, we are accelerating access to life-saving vaccines in the countries that need them the most.

In this section, we explain Gavi’s partnership model and explain the role of each of the Vaccine Alliance’s members.

The Bill & Melinda Gates Foundation's initial pledge of US$ 750 million in 1999 provided the seed money to launch Gavi.

As a founding member of Gavi and the UN's specialist agency on global health issues, WHO is a key Vaccine Alliance partner.

As the world's biggest buyer and supplier of vaccines for developing countries, UNICEF has a pivotal role in the Vaccine Alliance.

The World Bank brings the expertise of the world's biggest source of development assistance to the Vaccine Alliance.

Civil society: driving increased equity in immunisation

Gavi’s new Civil Society and Community Engagement (CSCE) approach ushers in a new era in building equity in immunisation. At the core is the goal to catalyse and strengthen strategic partnerships between governments and civil society…

Last updated: 23 Jun 2023

Subscribe to our newsletter